This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Shenzhen Mindray Animal Medical Technology Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Shengxi Wang in Sample Analysis Technology.
Introduction
Shengxi Wang is an accomplished inventor based in Shenzhen, China. He has made significant contributions to the field of medical technology, particularly in sample analysis methods. His innovative approach has the potential to enhance diagnostic accuracy in clinical settings.
Latest Patents
Shengxi Wang holds a patent for a "Sample analysis apparatus and sample analysis method." This invention involves obtaining a first light signal by irradiating a first test sample from blood and a first-channel reagent to differentiate various types of white blood cells, including neutrophils, eosinophils, lymphocytes, and monocytes. Additionally, it includes obtaining a second light signal from a second test sample and counting nucleated red blood cells and lymphocytes based on this signal. The method also allows for the correction of lymphocyte results if inaccuracies are detected.
Career Highlights
Shengxi Wang is currently employed at Shenzhen Mindray Animal Medical Technology Co., Ltd. His work at this company focuses on advancing medical technologies that improve animal health and diagnostics. His expertise in sample analysis has positioned him as a key player in the development of innovative medical solutions.
Collaborations
Shengxi Wang collaborates with talented professionals in his field, including Fangang Kong and Tao Shi. These partnerships foster a creative environment that encourages the development of groundbreaking technologies.
Conclusion
Shengxi Wang's contributions to sample analysis technology exemplify the impact of innovation in medical diagnostics. His work not only enhances the accuracy of blood analysis but also demonstrates the importance of collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile